Arcadia Biosciences, Inc.·4

Feb 4, 2:01 PM ET

Jacot Stanley Jr 4

4 · Arcadia Biosciences, Inc. · Filed Feb 4, 2022

Insider Transaction Report

Form 4
Period: 2022-02-02
Jacot Stanley Jr
Chief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-02-02+316,108316,108 total
    Exercise: $0.91Exp: 2032-02-02Common Stock (316,108 underlying)
Footnotes (1)
  • [F1]25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION